Bicara Therapeutics (BCAX) Depreciation and Depletion (2023 - 2026)
Bicara Therapeutics posted quarterly Depreciation and Depletion of $44000.0 for Q1 2026, up 131.58% year-on-year from $19000.0 in Q1 2025, and up 2.33% on a QoQ basis from $43000.0 in Q4 2025.
Bicara Therapeutics (BCAX) has 4 years of Depreciation and Depletion data on file, last reported at $44000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion rose 131.58% year-over-year to $44000.0; the trailing twelve-month figure through Mar 2026 stood at $130000.0 (up 109.68% YoY), and the FY2025 full-year result was $105000.0, up 87.5% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $44000.0, up from $43000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $44000.0 in Q1 2026 and bottomed at $13000.0 in Q1 2024.
- The 4-year median for Depreciation and Depletion is $17000.0 (2024), against an average of $21900.0.
- The widest annual swing landed in 2024, when Depreciation and Depletion increased 7.14%; it then surged 186.67% in 2025.
- A 4-year view of Depreciation and Depletion shows it stood at $14000.0 in 2023, then rose by 7.14% to $15000.0 in 2024, then soared by 186.67% to $43000.0 in 2025, then increased by 2.33% to $44000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $44000.0 (Q1 2026), $43000.0 (Q4 2025), and $24000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Bicara Therapeutics | 1.25 Bn | 1.25 Bn | - | 44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44,000.00 |
| Mar 31, 2026 | 44,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Dec 31, 2023 | 14,000.00 |